“…It is known that thalassemic patients are affected by immune changes, including alterations in lymphocyte subsets, abnormal levels of cytokines and the presence of alloantibodies [21,22,23,24,25,26]. There is strong evidence of an association between endothelial cell activation and vascular complications in patients with β-thalassemia [6], whereas activation of the vascular endothelium is considered an important facet of inflammation, atherosclerosis [27,28,29], vasculitis and thrombosis [30,31,32,33,34,35,36].…”